Cerebral Malaria and Neurological Outcomes in Pediatric Populations

Cerebral malaria remains a leading cause of acute neurological dysfunction and mortality in children living in malaria-endemic regions. It is characterised by coma and dense parasitaemia in the absence of other causes, and is frequently complicated by microvascular obstruction, blood–brain barrier disruption and neuroinflammation. Survivors often suffer a spectrum of neurosequelae, ranging from cognitive impairments and behavioural disturbances to motor deficits, epilepsy and long-term mental health disorders. Advances in molecular diagnostics, neuroradiological imaging and biomarker analysis have improved our understanding of the pathophysiological processes that underlie neuronal injury in cerebral malaria. The global significance of this burden has prompted studies investigating early predictors of poor outcome, risk stratification tools such as retinopathy grading, and targeted interventions to mitigate long-term disability in paediatric survivors.

Research from Nature Portfolio

Recent studies have examined social, clinical and immune determinants of malarial retinopathy and short-term neurological outcomes in young children hospitalised with cerebral malaria. In a prospective cohort of children aged two to six years, retinopathy detected by direct ophthalmoscopy shortly after admission was associated with persistence of neurological deficits at discharge and at three weeks post-admission. Plasma levels of endothelial activation markers correlated with the severity of neurocognitive impairment, suggesting that endothelial dysfunction may serve as an early biomarker of brain injury. These findings highlight the value of combining bedside retinal examination with biomarker profiling to identify high-risk survivors who may benefit from intensified follow-up and rehabilitative care.

Cerebral Malaria and Neurological Outcomes in Pediatric Populations publication trend

The graph below shows the total number of articles in cerebral malaria and neurological outcomes in pediatric populations across all publications each year (not limited to Nature Index journals).

Technical terms

Cerebral malaria: A severe form of P. falciparum infection characterised by coma (Blantyre Coma Scale ≤2), high parasitaemia and exclusion of other causes of encephalopathy.

Malarial retinopathy: Specific retinal changes—including whitening, vessel discolouration and haemorrhages—observable by ophthalmoscopy that improve diagnostic specificity for cerebral malaria.

Neurosequelae: Persistent or late-onset neurological impairments—such as cognitive deficits, motor dysfunction or epilepsy—occurring after acute central nervous system injury.

Endothelial activation: A pathological state in which vascular endothelial cells express adhesion molecules and release inflammatory mediators, contributing to blood–brain barrier disruption and microvascular occlusion.

References

1. Aetiologies, neuroradiological features, and risk factors for mortality and long-term neurosequelae of febrile coma in Malawian children: a prospective cohort study. The Lancet Global Health (2025).
2. Determinants of retinopathy and short-term neurological outcomes after cerebral malaria. Scientific Reports (2025).
3. Association of severe malaria with cognitive and behavioural outcomes in low- and middle-income countries: a meta-analysis and systematic review. Malaria Journal (2023).
4. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. The Lancet Neurology (2010).